Suri, Ajit <br/><br/>
Absorption, Distribution, and Excretion of the Investigational Agent Orteronel (TAK-700) in Healthy Male Subjects: A Phase 1, Open-Label, Single-Dose Study.  [electronic resource] 

 -  Clinical pharmacology in drug development  May 2016 
 - 180-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>2160-7648 
<br/><br/><label>Standard No.: </label>10.1002/cpdd.234  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Chromatography, Liquid<br/>Cytochrome P-450 Enzyme Inhibitors--adverse effects<br/>Half-Life<br/>Humans<br/>Imidazoles--adverse effects<br/>Male<br/>Naphthalenes--adverse effects<br/>Steroid 17-alpha-Hydroxylase--antagonists & inhibitors<br/>Tandem Mass Spectrometry<br/>Young Adult